img

Global and United States CAR T-Cell-Based Drug Market Report & Forecast 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global and United States CAR T-Cell-Based Drug Market Report & Forecast 2024-2034

Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer.
Market Analysis and InsightsGlobal and United States CAR T-Cell-Based Drug Market
This report focuses on global and United States CAR T-Cell-Based Drug market, also covers the segmentation data of other regions in regional level and county level.
The global CAR T-Cell-Based Drug revenue was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the review period (2024-2034).
In United States the CAR T-Cell-Based Drug revenue is expected to grow from US$ million in 2024 to US$ million by 2034, at a CAGR of % during the forecast period 2024-2034.
The global key players of CAR T-Cell-Based Drug include Novartis, Gilead Sciences, Bristol-Myers Squibb, J & J, JW Therapeutics, FOSUNKite, CARsgen Therapeutics, Autolus Therapeutics and Sorrento Therapeutics, etc. The global five biggest players hold a share of % in 2024.
Global CAR T-Cell-Based Drug Scope and Market Size
CAR T-Cell-Based Drug market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global CAR T-Cell-Based Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2034.
For United States market, this report focuses on the CAR T-Cell-Based Drug market size by players, by Type and by Application, for the period 2018-2034. The key players include the global and local players, which play important roles in United States.



By Company


Novartis
Gilead Sciences
Bristol-Myers Squibb
J & J
JW Therapeutics
FOSUNKite
CARsgen Therapeutics
Autolus Therapeutics
Sorrento Therapeutics
Mustang Bio
Bluebird Bio
Cellectis
Allogene Therapeutics
Celyad
Segment by Type
CD19-targeted
BCMA-targeted

Segment by Application


Lymphoma
Multiple Myeloma
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces CAR T-Cell-Based Drug definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of CAR T-Cell-Based Drug companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of CAR T-Cell-Based Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, CAR T-Cell-Based Drug revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions

Table of Content

1 Study Coverage
1.1 CAR T-Cell-Based Drug Product Introduction
1.2 Global CAR T-Cell-Based Drug Outlook 2018 VS 2024 VS 2034
1.2.1 Global CAR T-Cell-Based Drug Market Size for the Year 2018-2034
1.2.2 United States CAR T-Cell-Based Drug Market Size for the Year 2018-2034
1.3 CAR T-Cell-Based Drug Market Size, United States VS Global, 2018 VS 2024 VS 2034
1.3.1 The Market Share of United States CAR T-Cell-Based Drug in Global, 2018 VS 2024 VS 2034
1.3.2 The Growth Rate of CAR T-Cell-Based Drug Market Size, United States VS Global, 2018 VS 2024 VS 2034
1.4 CAR T-Cell-Based Drug Market Dynamics
1.4.1 CAR T-Cell-Based Drug Industry Trends
1.4.2 CAR T-Cell-Based Drug Market Drivers
1.4.3 CAR T-Cell-Based Drug Market Challenges
1.4.4 CAR T-Cell-Based Drug Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 CAR T-Cell-Based Drug by Type
2.1 CAR T-Cell-Based Drug Market Segment by Type
2.1.1 CD19-targeted
2.1.2 BCMA-targeted
2.2 Global CAR T-Cell-Based Drug Market Size by Type (2018, 2024 & 2034)
2.3 Global CAR T-Cell-Based Drug Market Size by Type (2018-2034)
2.4 United States CAR T-Cell-Based Drug Market Size by Type (2018, 2024 & 2034)
2.5 United States CAR T-Cell-Based Drug Market Size by Type (2018-2034)
3 CAR T-Cell-Based Drug by Application
3.1 CAR T-Cell-Based Drug Market Segment by Application
3.1.1 Lymphoma
3.1.2 Multiple Myeloma
3.2 Global CAR T-Cell-Based Drug Market Size by Application (2018, 2024 & 2034)
3.3 Global CAR T-Cell-Based Drug Market Size by Application (2018-2034)
3.4 United States CAR T-Cell-Based Drug Market Size by Application (2018, 2024 & 2034)
3.5 United States CAR T-Cell-Based Drug Market Size by Application (2018-2034)
4 Global CAR T-Cell-Based Drug Competitor Landscape by Company
4.1 Global CAR T-Cell-Based Drug Market Size by Company
4.1.1 Global Key Companies of CAR T-Cell-Based Drug, Ranked by Revenue (2024)
4.1.2 Global CAR T-Cell-Based Drug Revenue by Player (2018-2023)
4.2 Global CAR T-Cell-Based Drug Concentration Ratio (CR)
4.2.1 CAR T-Cell-Based Drug Market Concentration Ratio (CR) (2018-2023)
4.2.2 Global Top 5 and Top 10 Largest Companies of CAR T-Cell-Based Drug in 2024
4.2.3 Global CAR T-Cell-Based Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of CAR T-Cell-Based Drug Head office and Area Served
4.4 Global Key Players of CAR T-Cell-Based Drug, Product and Application
4.5 Global Key Players of CAR T-Cell-Based Drug, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 United States CAR T-Cell-Based Drug Market Size by Company
4.7.1 Key Players of CAR T-Cell-Based Drug in United States, Ranked by Revenue (2024)
4.7.2 United States CAR T-Cell-Based Drug Revenue by Players (2021, 2024 & 2023)
5 Global CAR T-Cell-Based Drug Market Size by Region
5.1 Global CAR T-Cell-Based Drug Market Size by Region: 2018 VS 2024 VS 2034
5.2 Global CAR T-Cell-Based Drug Market Size by Region (2018-2034)
5.2.1 Global CAR T-Cell-Based Drug Market Size by Region: 2018-2023
5.2.2 Global CAR T-Cell-Based Drug Market Size by Region (2024-2034)
6 Americas
6.1 Americas CAR T-Cell-Based Drug Market Size YoY Growth 2018-2034
6.2 Americas CAR T-Cell-Based Drug Market Size by Type
6.2.1 Americas CAR T-Cell-Based Drug Market Size by Type (2018-2023)
6.2.2 Americas CAR T-Cell-Based Drug Market Size by Type (2024-2034)
6.2.3 Americas CAR T-Cell-Based Drug Market Share by Type (2018-2034)
6.3 Americas CAR T-Cell-Based Drug Market Size by Application
6.3.1 Americas CAR T-Cell-Based Drug Market Size by Application (2018-2023)
6.3.2 Americas CAR T-Cell-Based Drug Market Size by Application (2024-2034)
6.3.3 Americas CAR T-Cell-Based Drug Market Share by Application (2018-2034)
6.4 Americas CAR T-Cell-Based Drug Market Facts & Figures by Country (2018, 2024 & 2034)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA CAR T-Cell-Based Drug Market Size YoY Growth 2018-2034
7.2 EMEA CAR T-Cell-Based Drug Market Size by Type
7.2.1 EMEA CAR T-Cell-Based Drug Market Size by Type (2018-2023)
7.2.2 EMEA CAR T-Cell-Based Drug Market Size by Type (2024-2034)
7.2.3 EMEA CAR T-Cell-Based Drug Market Share by Type (2018-2034)
7.3 EMEA CAR T-Cell-Based Drug Market Size by Application
7.3.1 EMEA CAR T-Cell-Based Drug Market Size by Application (2018-2023)
7.3.2 EMEA CAR T-Cell-Based Drug Market Size by Application (2024-2034)
7.3.3 EMEA CAR T-Cell-Based Drug Market Share by Application (2018-2034)
7.4 EMEA CAR T-Cell-Based Drug Market Facts & Figures by Country (2018, 2024 & 2034)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China CAR T-Cell-Based Drug Market Size YoY Growth 2018-2034
8.2 China CAR T-Cell-Based Drug Market Size by Type
8.2.1 China CAR T-Cell-Based Drug Market Size by Type (2018-2023)
8.2.2 China CAR T-Cell-Based Drug Market Size by Type (2024-2034)
8.2.3 China CAR T-Cell-Based Drug Market Share by Type (2018-2034)
8.3 China CAR T-Cell-Based Drug Market Size by Application
8.3.1 China CAR T-Cell-Based Drug Market Size by Application (2018-2023)
8.3.2 China CAR T-Cell-Based Drug Market Size by Application (2024-2034)
8.3.3 China CAR T-Cell-Based Drug Market Share by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC CAR T-Cell-Based Drug Market Size YoY Growth 2018-2034
9.2 APAC CAR T-Cell-Based Drug Market Size by Type
9.2.1 APAC CAR T-Cell-Based Drug Market Size by Type (2018-2023)
9.2.2 APAC CAR T-Cell-Based Drug Market Size by Type (2024-2034)
9.2.3 APAC CAR T-Cell-Based Drug Market Share by Type (2018-2034)
9.3 APAC CAR T-Cell-Based Drug Market Size by Application
9.3.1 APAC CAR T-Cell-Based Drug Market Size by Application (2018-2023)
9.3.2 APAC CAR T-Cell-Based Drug Market Size by Application (2024-2034)
9.3.3 APAC CAR T-Cell-Based Drug Market Share by Application (2018-2034)
9.4 APAC CAR T-Cell-Based Drug Market Facts & Figures by Country (2018, 2024 & 2034)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 Southeast Asia
9.4.5 India
10 Key Players Profiles
10.1 Novartis
10.1.1 Novartis Company Details
10.1.2 Novartis Business Overview
10.1.3 Novartis CAR T-Cell-Based Drug Introduction
10.1.4 Novartis Revenue in CAR T-Cell-Based Drug Business (2018-2023)
10.1.5 Novartis Recent Development
10.2 Gilead Sciences
10.2.1 Gilead Sciences Company Details
10.2.2 Gilead Sciences Business Overview
10.2.3 Gilead Sciences CAR T-Cell-Based Drug Introduction
10.2.4 Gilead Sciences Revenue in CAR T-Cell-Based Drug Business (2018-2023)
10.2.5 Gilead Sciences Recent Development
10.3 Bristol-Myers Squibb
10.3.1 Bristol-Myers Squibb Company Details
10.3.2 Bristol-Myers Squibb Business Overview
10.3.3 Bristol-Myers Squibb CAR T-Cell-Based Drug Introduction
10.3.4 Bristol-Myers Squibb Revenue in CAR T-Cell-Based Drug Business (2018-2023)
10.3.5 Bristol-Myers Squibb Recent Development
10.4 J & J
10.4.1 J & J Company Details
10.4.2 J & J Business Overview
10.4.3 J & J CAR T-Cell-Based Drug Introduction
10.4.4 J & J Revenue in CAR T-Cell-Based Drug Business (2018-2023)
10.4.5 J & J Recent Development
10.5 JW Therapeutics
10.5.1 JW Therapeutics Company Details
10.5.2 JW Therapeutics Business Overview
10.5.3 JW Therapeutics CAR T-Cell-Based Drug Introduction
10.5.4 JW Therapeutics Revenue in CAR T-Cell-Based Drug Business (2018-2023)
10.5.5 JW Therapeutics Recent Development
10.6 FOSUNKite
10.6.1 FOSUNKite Company Details
10.6.2 FOSUNKite Business Overview
10.6.3 FOSUNKite CAR T-Cell-Based Drug Introduction
10.6.4 FOSUNKite Revenue in CAR T-Cell-Based Drug Business (2018-2023)
10.6.5 FOSUNKite Recent Development
10.7 CARsgen Therapeutics
10.7.1 CARsgen Therapeutics Company Details
10.7.2 CARsgen Therapeutics Business Overview
10.7.3 CARsgen Therapeutics CAR T-Cell-Based Drug Introduction
10.7.4 CARsgen Therapeutics Revenue in CAR T-Cell-Based Drug Business (2018-2023)
10.7.5 CARsgen Therapeutics Recent Development
10.8 Autolus Therapeutics
10.8.1 Autolus Therapeutics Company Details
10.8.2 Autolus Therapeutics Business Overview
10.8.3 Autolus Therapeutics CAR T-Cell-Based Drug Introduction
10.8.4 Autolus Therapeutics Revenue in CAR T-Cell-Based Drug Business (2018-2023)
10.8.5 Autolus Therapeutics Recent Development
10.9 Sorrento Therapeutics
10.9.1 Sorrento Therapeutics Company Details
10.9.2 Sorrento Therapeutics Business Overview
10.9.3 Sorrento Therapeutics CAR T-Cell-Based Drug Introduction
10.9.4 Sorrento Therapeutics Revenue in CAR T-Cell-Based Drug Business (2018-2023)
10.9.5 Sorrento Therapeutics Recent Development
10.10 Mustang Bio
10.10.1 Mustang Bio Company Details
10.10.2 Mustang Bio Business Overview
10.10.3 Mustang Bio CAR T-Cell-Based Drug Introduction
10.10.4 Mustang Bio Revenue in CAR T-Cell-Based Drug Business (2018-2023)
10.10.5 Mustang Bio Recent Development
10.11 Bluebird Bio
10.11.1 Bluebird Bio Company Details
10.11.2 Bluebird Bio Business Overview
10.11.3 Bluebird Bio CAR T-Cell-Based Drug Introduction
10.11.4 Bluebird Bio Revenue in CAR T-Cell-Based Drug Business (2018-2023)
10.11.5 Bluebird Bio Recent Development
10.12 Cellectis
10.12.1 Cellectis Company Details
10.12.2 Cellectis Business Overview
10.12.3 Cellectis CAR T-Cell-Based Drug Introduction
10.12.4 Cellectis Revenue in CAR T-Cell-Based Drug Business (2018-2023)
10.12.5 Cellectis Recent Development
10.13 Allogene Therapeutics
10.13.1 Allogene Therapeutics Company Details
10.13.2 Allogene Therapeutics Business Overview
10.13.3 Allogene Therapeutics CAR T-Cell-Based Drug Introduction
10.13.4 Allogene Therapeutics Revenue in CAR T-Cell-Based Drug Business (2018-2023)
10.13.5 Allogene Therapeutics Recent Development
10.14 Celyad
10.14.1 Celyad Company Details
10.14.2 Celyad Business Overview
10.14.3 Celyad CAR T-Cell-Based Drug Introduction
10.14.4 Celyad Revenue in CAR T-Cell-Based Drug Business (2018-2023)
10.14.5 Celyad Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List of Figure

List of Tables
Table 1. CAR T-Cell-Based Drug Market Size United States VS Global, CAGR (2018 VS 2024 VS 2034)
Table 2. CAR T-Cell-Based Drug Market Trends
Table 3. CAR T-Cell-Based Drug Market Drivers
Table 4. CAR T-Cell-Based Drug Market Challenges
Table 5. CAR T-Cell-Based Drug Market Restraints
Table 6. Global CAR T-Cell-Based Drug Market Size by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. United States CAR T-Cell-Based Drug Market Size by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global CAR T-Cell-Based Drug Market Size by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. United States CAR T-Cell-Based Drug Market Size by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 10. Global Key Companies of CAR T-Cell-Based Drug, Ranked by Revenue (2024) & (US$ Million)
Table 11. Global CAR T-Cell-Based Drug Revenue by Player, (US$ Million), 2018-2023
Table 12. Global CAR T-Cell-Based Drug Revenue Share by Player, 2018-2023
Table 13. Global CAR T-Cell-Based Drug Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global CAR T-Cell-Based Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR T-Cell-Based Drug as of 2024)
Table 15. Global Key Players of CAR T-Cell-Based Drug, Headquarters and Area Served
Table 16. Global Key Players of CAR T-Cell-Based Drug, Product and Application
Table 17. Global Key Players of CAR T-Cell-Based Drug, Date of Enter into This Industry
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Key Players of CAR T-Cell-Based Drug in United States, Ranked by Revenue (2024) & (US$ Million)
Table 20. United States CAR T-Cell-Based Drug Revenue by Players, (US$ Million), 2021, 2024 & 2023
Table 21. United States CAR T-Cell-Based Drug Revenue Share by Players, 2021, 2024 & 2023
Table 22. Global CAR T-Cell-Based Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 23. Global CAR T-Cell-Based Drug Market Size by Region (2018-2023) & (US$ Million)
Table 24. Global CAR T-Cell-Based Drug Market Size Forecast by Region (2024-2034) & (US$ Million)
Table 25. Americas CAR T-Cell-Based Drug Market Size by Type (2018-2023) & (US$ Million)
Table 26. Americas CAR T-Cell-Based Drug Market Size by Type (2024-2034) & (US$ Million)
Table 27. Americas CAR T-Cell-Based Drug Market Size by Application (2018-2023) & (US$ Million)
Table 28. Americas CAR T-Cell-Based Drug Market Size by Application (2024-2034) & (US$ Million)
Table 29. Americas CAR T-Cell-Based Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 30. Americas CAR T-Cell-Based Drug Market Size by Country (2018-2023) & (US$ Million)
Table 31. Americas CAR T-Cell-Based Drug Market Size by Country (2024-2034) & (US$ Million)
Table 32. EMEA CAR T-Cell-Based Drug Market Size by Type (2018-2023) & (US$ Million)
Table 33. EMEA CAR T-Cell-Based Drug Market Size by Type (2024-2034) & (US$ Million)
Table 34. EMEA CAR T-Cell-Based Drug Market Size by Application (2018-2023) & (US$ Million)
Table 35. EMEA CAR T-Cell-Based Drug Market Size by Application (2024-2034) & (US$ Million)
Table 36. EMEA CAR T-Cell-Based Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 37. EMEA CAR T-Cell-Based Drug Market Size by Country (2018-2023) & (US$ Million)
Table 38. EMEA CAR T-Cell-Based Drug Market Size by Country (2024-2034) & (US$ Million)
Table 39. China CAR T-Cell-Based Drug Market Size by Type (2018-2023) & (US$ Million)
Table 40. China CAR T-Cell-Based Drug Market Size by Type (2024-2034) & (US$ Million)
Table 41. China CAR T-Cell-Based Drug Market Size by Application (2018-2023) & (US$ Million)
Table 42. China CAR T-Cell-Based Drug Market Size by Application (2024-2034) & (US$ Million)
Table 43. China CAR T-Cell-Based Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 44. APAC CAR T-Cell-Based Drug Market Size by Type (2018-2023) & (US$ Million)
Table 45. APAC CAR T-Cell-Based Drug Market Size by Type (2024-2034) & (US$ Million)
Table 46. APAC CAR T-Cell-Based Drug Market Size by Application (2018-2023) & (US$ Million)
Table 47. APAC CAR T-Cell-Based Drug Market Size by Application (2024-2034) & (US$ Million)
Table 48. APAC CAR T-Cell-Based Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 49. APAC CAR T-Cell-Based Drug Market Size by Region (2018-2023) & (US$ Million)
Table 50. APAC CAR T-Cell-Based Drug Market Size by Region (2024-2034) & (US$ Million)
Table 51. Novartis Company Details
Table 52. Novartis Business Overview
Table 53. Novartis CAR T-Cell-Based Drug Product
Table 54. Novartis Revenue in CAR T-Cell-Based Drug Business (2018-2023) & (US$ Million)
Table 55. Novartis Recent Development
Table 56. Gilead Sciences Company Details
Table 57. Gilead Sciences Business Overview
Table 58. Gilead Sciences CAR T-Cell-Based Drug Product
Table 59. Gilead Sciences Revenue in CAR T-Cell-Based Drug Business (2018-2023) & (US$ Million)
Table 60. Gilead Sciences Recent Development
Table 61. Bristol-Myers Squibb Company Details
Table 62. Bristol-Myers Squibb Business Overview
Table 63. Bristol-Myers Squibb CAR T-Cell-Based Drug Product
Table 64. Bristol-Myers Squibb Revenue in CAR T-Cell-Based Drug Business (2018-2023) & (US$ Million)
Table 65. Bristol-Myers Squibb Recent Development
Table 66. J & J Company Details
Table 67. J & J Business Overview
Table 68. J & J CAR T-Cell-Based Drug Product
Table 69. J & J Revenue in CAR T-Cell-Based Drug Business (2018-2023) & (US$ Million)
Table 70. J & J Recent Development
Table 71. JW Therapeutics Company Details
Table 72. JW Therapeutics Business Overview
Table 73. JW Therapeutics CAR T-Cell-Based Drug Product
Table 74. JW Therapeutics Revenue in CAR T-Cell-Based Drug Business (2018-2023) & (US$ Million)
Table 75. JW Therapeutics Recent Development
Table 76. FOSUNKite Company Details
Table 77. FOSUNKite Business Overview
Table 78. FOSUNKite CAR T-Cell-Based Drug Product
Table 79. FOSUNKite Revenue in CAR T-Cell-Based Drug Business (2018-2023) & (US$ Million)
Table 80. FOSUNKite Recent Development
Table 81. CARsgen Therapeutics Company Details
Table 82. CARsgen Therapeutics Business Overview
Table 83. CARsgen Therapeutics CAR T-Cell-Based Drug Product
Table 84. CARsgen Therapeutics Revenue in CAR T-Cell-Based Drug Business (2018-2023) & (US$ Million)
Table 85. CARsgen Therapeutics Recent Development
Table 86. Autolus Therapeutics Company Details
Table 87. Autolus Therapeutics Business Overview
Table 88. Autolus Therapeutics CAR T-Cell-Based Drug Product
Table 89. Autolus Therapeutics Revenue in CAR T-Cell-Based Drug Business (2018-2023) & (US$ Million)
Table 90. Autolus Therapeutics Recent Development
Table 91. Sorrento Therapeutics Company Details
Table 92. Sorrento Therapeutics Business Overview
Table 93. Sorrento Therapeutics CAR T-Cell-Based Drug Product
Table 94. Sorrento Therapeutics Revenue in CAR T-Cell-Based Drug Business (2018-2023) & (US$ Million)
Table 95. Sorrento Therapeutics Recent Development
Table 96. Mustang Bio Company Details
Table 97. Mustang Bio Business Overview
Table 98. Mustang Bio CAR T-Cell-Based Drug Product
Table 99. Mustang Bio Revenue in CAR T-Cell-Based Drug Business (2018-2023) & (US$ Million)
Table 100. Mustang Bio Recent Development
Table 101. Bluebird Bio Company Details
Table 102. Bluebird Bio Business Overview
Table 103. Bluebird Bio CAR T-Cell-Based Drug Product
Table 104. Bluebird Bio Revenue in CAR T-Cell-Based Drug Business (2018-2023) & (US$ Million)
Table 105. Bluebird Bio Recent Development
Table 106. Cellectis Company Details
Table 107. Cellectis Business Overview
Table 108. Cellectis CAR T-Cell-Based Drug Product
Table 109. Cellectis Revenue in CAR T-Cell-Based Drug Business (2018-2023) & (US$ Million)
Table 110. Cellectis Recent Development
Table 111. Allogene Therapeutics Company Details
Table 112. Allogene Therapeutics Business Overview
Table 113. Allogene Therapeutics CAR T-Cell-Based Drug Product
Table 114. Allogene Therapeutics Revenue in CAR T-Cell-Based Drug Business (2018-2023) & (US$ Million)
Table 115. Allogene Therapeutics Recent Development
Table 116. Celyad Company Details
Table 117. Celyad Business Overview
Table 118. Celyad CAR T-Cell-Based Drug Product
Table 119. Celyad Revenue in CAR T-Cell-Based Drug Business (2018-2023) & (US$ Million)
Table 120. Celyad Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. CAR T-Cell-Based Drug Product Picture
Figure 2. Global CAR T-Cell-Based Drug Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 3. Global CAR T-Cell-Based Drug Market Size 2018-2034 (US$ Million)
Figure 4. United States CAR T-Cell-Based Drug Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 5. United States CAR T-Cell-Based Drug Market Size 2018-2034 (US$ Million)
Figure 6. United States CAR T-Cell-Based Drug Market Share in Global 2018-2034
Figure 7. CAR T-Cell-Based Drug Report Years Considered
Figure 8. Product Picture of CD19-targeted
Figure 9. Product Picture of BCMA-targeted
Figure 10. Global CAR T-Cell-Based Drug Market Share by Type in 2024 & 2034
Figure 11. Global CAR T-Cell-Based Drug Market Size by Type (2018-2034) & (US$ Million)
Figure 12. Global CAR T-Cell-Based Drug Market Share by Type (2018-2034)
Figure 13. United States CAR T-Cell-Based Drug Market Share by Type in 2024 & 2034
Figure 14. United States CAR T-Cell-Based Drug Market Size by Type (2018-2034) & (US$ Million)
Figure 15. United States CAR T-Cell-Based Drug Market Share by Type (2018-2034)
Figure 16. Product Picture of Lymphoma
Figure 17. Product Picture of Multiple Myeloma
Figure 18. Global CAR T-Cell-Based Drug Market Share by Application in 2024 & 2034
Figure 19. Global CAR T-Cell-Based Drug Market Size by Application (2018-2034) & (US$ Million)
Figure 20. Global CAR T-Cell-Based Drug Market Share by Application (2018-2034)
Figure 21. United States CAR T-Cell-Based Drug Market Share by Application in 2024 & 2034
Figure 22. United States CAR T-Cell-Based Drug Market Size by Application (2018-2034) & (US$ Million)
Figure 23. United States CAR T-Cell-Based Drug Market Share by Application (2018-2034)
Figure 24. The Top 5 and 10 Largest Companies of CAR T-Cell-Based Drug in the World: Market Share by CAR T-Cell-Based Drug Revenue in 2024
Figure 25. Global CAR T-Cell-Based Drug Market Size Market Share by Region: 2018 VS 2024 VS 2034
Figure 26. Global CAR T-Cell-Based Drug Market Share by Region (2018-2034)
Figure 27. Americas CAR T-Cell-Based Drug Market Size Growth Rate 2018-2034 (US$ Million)
Figure 28. Americas CAR T-Cell-Based Drug Market Share by Type (2018-2034)
Figure 29. Americas CAR T-Cell-Based Drug Market Share by Application (2018-2034)
Figure 30. United States CAR T-Cell-Based Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 31. Canada CAR T-Cell-Based Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 32. Mexico CAR T-Cell-Based Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 33. Brazil CAR T-Cell-Based Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 34. EMEA CAR T-Cell-Based Drug Market Size Growth Rate 2018-2034 (US$ Million)
Figure 35. EMEA CAR T-Cell-Based Drug Market Share by Type (2018-2034)
Figure 36. EMEA CAR T-Cell-Based Drug Market Share by Application (2018-2034)
Figure 37. Europe CAR T-Cell-Based Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 38. Middle East CAR T-Cell-Based Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 39. Africa CAR T-Cell-Based Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 40. China CAR T-Cell-Based Drug Market Size Growth Rate 2018-2034 (US$ Million)
Figure 41. China CAR T-Cell-Based Drug Market Share by Type (2018-2034)
Figure 42. China CAR T-Cell-Based Drug Market Share by Application (2018-2034)
Figure 43. APAC CAR T-Cell-Based Drug Market Size Growth Rate 2018-2034 (US$ Million)
Figure 44. APAC CAR T-Cell-Based Drug Market Share by Type (2018-2034)
Figure 45. APAC CAR T-Cell-Based Drug Market Share by Application (2018-2034)
Figure 46. Japan CAR T-Cell-Based Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 47. South Korea CAR T-Cell-Based Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 48. China Taiwan CAR T-Cell-Based Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 49. Southeast Asia CAR T-Cell-Based Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 50. India CAR T-Cell-Based Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 51. Novartis Revenue Growth Rate in CAR T-Cell-Based Drug Business (2018-2023)
Figure 52. Gilead Sciences Revenue Growth Rate in CAR T-Cell-Based Drug Business (2018-2023)
Figure 53. Bristol-Myers Squibb Revenue Growth Rate in CAR T-Cell-Based Drug Business (2018-2023)
Figure 54. J & J Revenue Growth Rate in CAR T-Cell-Based Drug Business (2018-2023)
Figure 55. JW Therapeutics Revenue Growth Rate in CAR T-Cell-Based Drug Business (2018-2023)
Figure 56. FOSUNKite Revenue Growth Rate in CAR T-Cell-Based Drug Business (2018-2023)
Figure 57. CARsgen Therapeutics Revenue Growth Rate in CAR T-Cell-Based Drug Business (2018-2023)
Figure 58. Autolus Therapeutics Revenue Growth Rate in CAR T-Cell-Based Drug Business (2018-2023)
Figure 59. Sorrento Therapeutics Revenue Growth Rate in CAR T-Cell-Based Drug Business (2018-2023)
Figure 60. Mustang Bio Revenue Growth Rate in CAR T-Cell-Based Drug Business (2018-2023)
Figure 61. Bluebird Bio Revenue Growth Rate in CAR T-Cell-Based Drug Business (2018-2023)
Figure 62. Cellectis Revenue Growth Rate in CAR T-Cell-Based Drug Business (2018-2023)
Figure 63. Allogene Therapeutics Revenue Growth Rate in CAR T-Cell-Based Drug Business (2018-2023)
Figure 64. Celyad Revenue Growth Rate in CAR T-Cell-Based Drug Business (2018-2023)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries